Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes

Susan Van Dieren, Andre Kengne, John Chalmers, Joline Beulens, Mark Cooper, Diederick Grobbee, Stephen Harrap, Giuseppe Mancia, Bruce Neal, Anushka Patel, Neil Poulter, Yvonne Van Der Schouw, Mark Woodward, Sophia Zoungas

    Research output: Contribution to journalArticle

    14 Citations (Scopus)

    Abstract

    Aims: To asses differences in treatment effects of a fixed combination of perindopril-indapamide on major clinical outcomes in patients with type 2 diabetes across subgroups of cardiovascular risk. Methods: 11,140 participants with type 2 diabetes, from the ADVANCE trial, were randomized to perindopril-indapamide or matching placebo. The Framingham equation was used to calculate 5-year CVD risk and to divide participants into two risk groups, moderate-high risk (<25% and no history of macrovascular disease), very high risk (>25% and/or history of macrovascular disease). Endpoints were macrovascular and microvascular events. Results: The mean age of participants was 66 years (42.5% female). 1000 macrovascular and 916 microvascular events were recorded over follow-up of 4.3 years. Relative treatment effects were similar across risk groups, (all P-values for heterogeneity ≥0.38). Hazard ratios for combined macro- and microvascular events were 0.89 (0.77-1.03) for the moderate-high risk and 0.92 (0.81-1.03) for the very high risk. Absolute treatment effects tended to be greater in the high risk groups although differences were not statistically significant (P>0.05). Conclusions: Relative effects of blood pressure lowering with perindopril-indapamide on cardiovascular outcomes were similar across risk groups whilst absolute effects trended to be greater in the high risk group.

    Original languageEnglish
    Pages (from-to)83-90
    Number of pages8
    JournalDiabetes Research and Clinical Practice
    Volume98
    Issue number1
    DOIs
    Publication statusPublished - 2012

    Fingerprint Dive into the research topics of 'Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes'. Together they form a unique fingerprint.

  • Cite this

    Van Dieren, S., Kengne, A., Chalmers, J., Beulens, J., Cooper, M., Grobbee, D., Harrap, S., Mancia, G., Neal, B., Patel, A., Poulter, N., Van Der Schouw, Y., Woodward, M., & Zoungas, S. (2012). Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. Diabetes Research and Clinical Practice, 98(1), 83-90. https://doi.org/10.1016/j.diabres.2012.05.002